{"organizations": [], "uuid": "59e2599f5b3c289b432a4d758b784af48c690fc6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novus-therapeutics-reports-q4-loss/brief-novus-therapeutics-reports-q4-loss-per-share-0-30-idUSASC09UGW", "country": "US", "domain_rank": 408, "title": "BRIEF-Novus Therapeutics Reports Q4 Loss Per Share $0.30", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-02T16:14:00.000+03:00", "replies_count": 0, "uuid": "59e2599f5b3c289b432a4d758b784af48c690fc6"}, "author": "", "url": "https://www.reuters.com/article/brief-novus-therapeutics-reports-q4-loss/brief-novus-therapeutics-reports-q4-loss-per-share-0-30-idUSASC09UGW", "ord_in_thread": 0, "title": "BRIEF-Novus Therapeutics Reports Q4 Loss Per Share $0.30", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "novus therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 2, 2018 / 1:14 PM / Updated 7 minutes ago BRIEF-Novus Therapeutics Reports Q4 Loss Per Share $0.30 Reuters Staff \nApril 2 (Reuters) - Novus Therapeutics Inc: \n* YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE \n* Q4 LOSS PER SHARE $0.30 Source text for Eikon:   (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-04-02T16:14:00.000+03:00", "crawled": "2018-04-02T16:31:40.029+03:00", "highlightTitle": ""}